xinning's profilexinning的共享空间___The Year ...PhotosBlogListsMore Tools Help

Blog


    August 30

    Allosteric and It's Correlated Terms (4)

     

     

     

    11.相关中文翻译:

    http://atp.life.nctu.edu.tw/~biocenter/sections.php?op=viewarticle&artid=74

     

    allosteric enzyme 异位调节酵素(变构酶)

     

    中文: 異位調節酵素
    說明:異位調節酵素多半是由2個以上的次單位所組成,包括具有酵素作用,可與效應物結合的催化次單位(catalytic subunit)及可與效應物結合的調節次單位(regulatory subunit)。當異位效應物與調節次單位結合時,其構造上會發生變化,並影響催化次單位,使得受質與酵素間的結合力變弱。
    定義:酵素分子與其他物質(如效應物effector)結合時,其結合位置並非酵素分子和受質(substrate)的結合部位,結果在酵素的分子結構上發生變化,因而酵素活性會被促進或抑制。這種現象稱為異位效應(allosteric effect),具有這種效應的酵素稱為異位調節酵素。異位效應是生物體中代謝調節的重要機制之一。

    active site 活性基
    在酶(enzyme)分子表面的裂縫,可与受质(substrate)分子表面特定区域結合并活化之。

    feedback inhibition 回馈抑制
    当体內某些物质或活动增加时,會回转抑制使其增加的主要因素或过程的一种生物控制的机制。


    Other interpretations:

    allosteric

    biochemistry, chemistry Of a binding site in a protein, usually an enzyme.

    The catalytic function of an enzyme may be modified by interaction with small molecules, not only at the active site, but also at a spatially distinct (allosteric) site of different specificity.

    Of a protein, a protein possessing such a site. An allosteric effector is a molecule bound at such a site that increases or decreases the activity of the enzyme.

    active site:  A specific region of an enzyme where a substrate binds and catalysis takes place (binding site).

    中国教材中的术语:

    变构部位 allosteric site
    变构调节 allosteric
    regulation
    变构激活剂 allosteric
    activator
    变构酶 allosteric
    enzyme
    变构效应 allosteric
    effect
    变构效应剂 allosteric
    effector
    变构抑制剂 allosteric inhibitor
     

    Allosteric and It's Correlated Terms (3)

     

     

     

    7. The nature of catalysis (protein)

         http://www.britannica.com/eb/article-72587/protein#72587.toc

           In a chemical reaction—for example, one in which substance A is converted into product B—a point of equilibrium eventually is reached at which no further chemical change occurs; i.e., the rate of conversion of A to B equals the rate of conversion of B to A. The so-called thermodynamic-equilibrium constant expresses this chemical equilibrium. A catalyst may be defined as a substance that accelerates a chemical reaction but is not consumed in the process. The amount of catalyst has no relationship to the quantity of substance altered; very small amounts of enzymes are very efficient catalysts. Because the presence of an enzyme accelerates the rate of conversion of a compound to a product, it accelerates the approach to equilibrium; it does not, however, influence the equilibrium point attained.

           The molecules in the watery medium of the cell are in constant thermal motion but, because they are more or less stable compounds, they would react only occasionally to form products in the absence of enzymes. There exists an energy barrier to the reaction of a molecule. The energy required to overcome the barrier to reaction is called the energy of activation. A reaction proceeds to equilibrium only if the molecules have sufficient energy of activation to form an activated complex, from which products can be derived. Enzymes greatly increase the chances for reactions by their ability to make large numbers of specific molecules more reactive (i.e., unstable) by forming intermediate compounds with them. The unstable intermediates quickly break down to form stable products, and the enzymes, unchanged by the reaction, are able to catalyze the formation of additional products.

     

         8. active site

     

    http://en.wikipedia.org/wiki/Active_site

        

          The active site of an enzyme contains the catalytic and binding sites. The structure and chemical properties of the active site allow the recognition and binding of the substrate.

         The active site is usually a small pocket at the surface of the enzyme that contains residues responsible for the substrate specificity (charge, hydrophobicity, steric hindrance) and catalytic residues which often act as proton donors or acceptors or are responsible for binding a cofactor such as PLP, TPP or NAD. The active site is also the site of inhibition of enzymes (see Enzyme inhibitor article).

     

    9. Enzyme’s Working Models

     

          There are several models of how enzymes work: the lock-and-key model and the induced fit model. Substrates bind to the active site of the enzyme or a specificity pocket through hydrogen bonds, hydrophobic interactions, temporary covalent bond or a combination of all of these. Residues of the active site will act as donors or acceptors of protons or other groups on the substrate to facilitate the reaction. In other words, the active site modifies the reaction mechanism in order to decrease the activation energy of the reaction. The product is usually unstable in the active site due to steric hindrances that force it to be released and return the enzyme to its initial state.

     

     10. Models of allosteric regulation

      (http://en.wikipedia.org/wiki/Allostery#Models_of_allosteric_regulation)

     

        Most allosteric effects can be explained by the concerted MWC model put forth by Monod, Wyman, and Changeux, or by the sequential model described by Koshland, Nemethy, and Filmer. Both postulate that enzyme subunits exist in one of two conformations, tensed (T) or relaxed (R), and that relaxed subunits bind substrate more readily than those in the tense state. The two models differ most in their assumptions about subunit interaction and the preexistence of both states.

        10-1. Concerted model

          The concerted model of allostery, also referred to as the symmetry model or MWC- model, postulates that enzyme subunits are connected in such a way that a conformational change in one subunit is necessarily conferred to all other subunits. Thus all subunits must exist in the same conformation. The model further holds that in the absence of any ligand (substrate or otherwise), the equilibrium favors one of the conformational states, T or R. The equilibrium can be shifted to the R or T state through the binding of one ligand (the allosteric effector or ligand) to a site that is different from the active site (the allosteric site).

          10-2. Sequential model

           The sequential model of allosteric regulation holds that subunits are not connected in such a way that a conformational change in one induces a similar change in the others. Thus, all enzyme subunits do not necessitate the same conformation. Moreover, the sequential model dictates that molecules of substrate bind via an induced fit protocol. In general, when a subunit randomly collides with a molecule of substrate, the active site essentially forms a glove around its substrate. While such an induced fit converts a subunit from the tensed state to relaxed state, it does not propagate the conformational change to adjacent subunits. Instead, substrate-binding at one subunit only slightly alters the structure of other subunits so that their binding sites are more receptive to substrate. To summarize:

    · subunits need not exist in the same conformation

    ·  molecules of substrate bind via induced-fit protocol

    · conformational changes are not propagated to all subunits

    · substrate-binding causes increased substrate affinity in adjacent subunits

     

     

    Allosteric and It's Correlated Terms(2)

     

                                                 

    4. allosteric control

            http://www.britannica.com/eb/article-9005828

         

          in enzymology, inhibition or activation of an enzyme by a small regulatory molecule that interacts at a site (allosteric site) other than the active site (at which catalytic activity occurs). The interaction changes the shape of the enzyme so as to affect the formation at the active site of the usual complex between the enzyme and its substrate (the compound upon which it acts to form a product). As a result, the ability of the enzyme to catalyze a reaction is modified. This is the basis of the so-called induced-fit theory, which states that the binding of a substrate or some other molecule to an enzyme causes a change in the shape of the enzyme so as to enhance or inhibit its activity.

    The regulatory molecule may be a product of a synthetic pathway and inhibit an enzyme in that pathway (see feedback inhibition), thereby preventing the further formation of itself. Other molecules act as activators; i.e., they interact with an enzyme so as to enhance the binding of the substrate to the enzyme, thus enhancing catalytic activity. The enzyme adenyl cyclase, itself activated by the hormone adrenaline (epinephrine), which is released when a mammal requires energy, catalyzes a reaction that results in the formation of the compound cyclic adenosine monophosphate (cyclic AMP). Cyclic AMP, in turn, activates enzymes that metabolize carbohydrates for energy production. A combination of allosteric activation and inhibition thus provides a way by which the cell can rapidly regulate needed substances.

     

    5. feedback inhibition

       http://www.britannica.com/eb/article-9033914/feedback-inhibition

         

          in enzymology, suppression of the activity of an enzyme, participating in a sequence of reactions by which a substance is synthesized, by a product of that sequence. When the product accumulates in a cell beyond an optimal amount, its production is decreased by inhibition of an enzyme involved in its synthesis. After the product has been utilized or broken down and its concentration thus decreased, the inhibition is relaxed, and the formation of the product resumes. Such enzymes, whose ability to catalyze a reaction depends upon molecules other than their substrates (the ones upon which they act to form a product), are said to be under allosteric control. Feedback inhibition is a mechanism by which the concentration of certain cell constituents is limited.

     

    6. The induced-fit theory (protein)

         http://www.britannica.com/eb/article-72596/protein#593882.hook

        

          The key–lock hypothesis (see above The nature of enzyme-catalyzed reactions) does not fully account for enzymatic action; i.e., certain properties of enzymes cannot be accounted for by the simple relationship between enzyme and substrate proposed by the key–lock hypothesis. A theory called the induced-fit theory retains the key–lock idea of a fit of the substrate at the active site but postulates in addition that the substrate must do more than simply fit into the already preformed shape of an active site. Rather, the theory states, the binding of the substrate to the enzyme must cause a change in the shape of the enzyme that results in the proper alignment of the catalytic groups on its surface. This concept has been likened to the fit of a hand in a glove, the hand (substrate) inducing a change in the shape of the glove (enzyme). Although some enzymes appear to function according to the older key–lock hypothesis, most apparently function according to the induced-fit theory.
           During step 1 in Figure 10, which illustrates the induced-fit theory, the substrate approaches the enzyme surface and induces a change in its shape that results in the correct alignment of the catalytic groups (indicated by triangles A and B). In the case of the digestive enzyme carboxypeptidase, the binding of the substrate causes a tyrosine molecule at the active site to move by as much as 15 angstroms. Circles C and D in the figure represent substrate-binding groups on the enzyme that are essential for catalytic activity. During step 2 the catalytic groups at the active site react with the substrate to form products. The products separate from the enzyme surface during step 3, and the enzyme is able to repeat the sequence.
             Nonsubstrate molecules that are too bulky (Figure 10D) or too small (Figure 10E) alter the shape of the enzyme so that a misalignment of catalytic groups A and B occurs; such molecules are not able to react even if they are attracted to the active site.
           The induced-fit theory explains a number of anomalous properties of enzymes; for example, “noncompetitive inhibition” (Figure 10F), in which a compound inhibits the reaction of an enzyme but does not prevent the binding of the substrate. In this case, the inhibitor compound I attracts the binding group C so that the catalytic group B is too far away from the substrate to react. The site at which the inhibitor binds to the enzyme is not the active site and is called an allosteric site. The inhibitor changes the shape of the active site to prevent catalysis without preventing binding of the substrate.
           Figure 10G
    shows the effect of an inhibitor (¢l), which distorts the active site by affecting the essential binding group D; as a result, the enzyme can no longer attract the substrate. In Figure 10H, a so-called activator molecule, X, affects the active site so that a nonsubstrate molecule is properly aligned and hence can react with the enzyme; X is called an allosteric activator of the reaction. Such activators can affect both binding and catalytic groups at the active site.
         Enzyme flexibility is extremely important because it provides a mechanism for regulating enzymatic activity. As shown in Figure 10F and G, the orientation at the active site can be disrupted by the binding of an inhibitor at a site other than the active site. Moreover, the enzyme can be activated by molecules that induce a proper alignment of the active site for a substrate that alone cannot induce this alignment (Figure 10H).

         As mentioned above, the sites that bind inhibitors and activators are called allosteric sites to distinguish them from active sites. Allosteric sites are in fact regulatory sites able to activate or inhibit enzymatic activity by influencing the shape of the enzyme. When the activator or inhibitor dissociates from the enzyme, it returns to its normal shape. Thus, the flexibility of the protein structure allows the operation of a simple, reversible control system similar to a thermostat. 

     

    Allosteric and It's Correlated Terms (1)

     

     

     

    1.allosteric.

        Pronunciation: "a-lo-'ster-ik; ( adjective)
        Etymology: all- + steric
        of, relating to, undergoing, or being a change in the shape and activity of a protein (as an enzyme) that results from combination with another substance at a point other than the chemically active site

     

    2. allosteric regulation

    http://en.wikipedia.org/wiki/Allosteric_regulation

     

          In biochemistry, allosteric regulation is the regulation of an enzyme or protein by binding an effector molecule at the protein's allosteric site (that is, a site other than the protein's active site). Effectors that enhance the protein's activity are referred to as allosteric activators, whereas those that decrease the protein's activity are called allosteric inhibitors. The term allostery comes from the Greek allos, "other," and stereos, "space," referring to the regulatory site of an allosteric protein's being separate from its active site. Allosteric regulation is a natural example of feedback control

     

    3. effector

         (http://en.wikipedia.org/wiki/Effector_%28biology%29)

           

           An effector is a molecule (originally referring to small molecules but now encompassing any regulatory molecule, includes proteins) that binds to a protein and thereby alters the activity of that protein. A modulator molecule binds to a regulatory site during allosteric modulation and allosterically modulates the shape of the protein.

        Types of effectors:

          3-1. Enzyme activators are molecules that bind to enzymes and increase their activity. These molecules are often involved in the allosteric regulation of enzymes in the control of metabolism. An example of an enzyme activator working in this way is fructose 2,6-bisphosphate, which activates phosphofructokinase 1 and increases the rate of glycolysis in response to the hormone glucagon.

          3-2. Enzyme inhibitors are molecules that bind to enzymes and decrease their activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. They are also used as herbicides and pesticides. Not all molecules that bind to enzymes are inhibitors; enzyme activators bind to enzymes and increase their enzymatic activity.

           The binding of an inhibitor can stop a substrate from entering the enzyme's active site and/or hinder the enzyme from catalysing its reaction. Inhibitor binding is either reversible or irreversible. Irreversible inhibitors usually react with the enzyme and change it chemically. These inhibitors modify key amino acid residues needed for enzymatic activity. In contrast, reversible inhibitors bind non-covalently and different types of inhibition are produced depending on whether these inhibitors bind the enzyme, the enzyme-substrate complex, or both.

           Many drug molecules are enzyme inhibitors, so their discovery and improvement is an active area of research in biochemistry and pharmacology. A medicinal enzyme inhibitor is often judged by its specificity (its lack of binding to other proteins) and its potency (its dissociation constant, which indicates the concentration needed to inhibit the enzyme). A high specificity and potency ensure that a drug will have few side effects and thus low toxicity.         Enzyme inhibitors also occur naturally and are involved in the regulation of metabolism. For example, enzymes in a metabolic pathway can be inhibited by downstream products. This type of negative feedback slows flux through a pathway when the products begin to build up and is an important way to maintain homeostasis in a cell. Other cellular enzyme inhibitors are proteins that specifically bind to and inhibit an enzyme target. This can help control enzymes that may be damaging to a cell, such as proteases or nucleases; a well-characterised example is the ribonuclease inhibitor, which binds to ribonucleases in one of the tightest known protein–protein interactions.[1] Natural enzyme inhibitors can also be poisons and are used as defenses against predators or as ways of killing prey. 

     
    August 17

    My son grows up, while with less our accompanying_儿子在我们不在家的日子里长大

     

     

    儿子在我们不在家的日子里长大

    My son grows up, while with less our accompanying......

     

     

    跟儿子的交流,每每彼此很开心。尤其是我,得到了太多的来自儿子的鼓励,他让我变得坚强,让我忘记自己的年龄…….每听到他的声音,我觉得我很Young!

     

    今天下午刚刚在法领馆renewschengen visa, 便接到了老公先生发来的短信,他又出发了!儿子又是一个人在家里!我放心不下。老公先生接着转发来一条短信,是儿子的。觉得挺有意思,这是一段对他对友情的理解:

     

    他们几个和我在祖国的东西南北,各一方。夏天保送了,于达到了山东大学,王烨到了南昌,还有不少同学到了上海。他们还说很想我。说要在我高考后在济南依聚一聚。感动啊!什么是真正的友情,我算是体会到了!原来我也是一个幸福的人,在初中的感情还能够跨越时间和空间的界限。在此刻,友情在温暖我的心,我还有什么可以奢求的呢?

     

    看到这一段,我完全明白儿子此时的心情…………

     

    接着,拨通了家里的电话,是儿子那略带男子汉磁性的声音.....

     

    儿子:Hi, 妈妈!”

         

           “妈妈读到你的短信,真是好羡慕你!”

     

    儿子:“羡慕我什么?”

     

    “你那么年轻!有那么美丽的青春!可以做你想做的很多事情!”

     

    儿子:“是啊,可是我现在还是要好好准备!”

     

    “没问题的!我绝对相信你!妈妈的条件就不如你了,你是朝阳,妈妈已近落日黄昏了!我只好倍加努力了!”

     

    儿子:“不能这么说吗!真么是黄昏呢? 至少是午后的烈日!”

     

    …….

     

    儿子“我正在考虑怎么把生日礼物送到你手里。我在联系瑞士的邮政……我想还是玫瑰比较好..

     

    “哦! 谢谢你,总是你第一个想着我!”

     

    儿子“不,还有我爸爸也想着你!其实,我姥姥最想着你!”

     

        “我也很想你们!把想念保存起来吧!去做更值得做的的事情!生日那天,我不在日内瓦,我用旅行作为大家对我的生日的祝贺”。

     

    儿子:“那好,我提前祝你生日快乐!”

    ……………..

     

    我算了一下,在儿子读书的近12年中,我花了近七年,离开他,去圆我的读书梦……没想到,没完没了…….

     

    小学的时候,儿子的作文凡是得高分的,都是写的跟妈妈有关的故事。老师说,你的儿子是在想妈妈的日子里长大的…..

     

    上初中的时候,他的语文老师很惊讶,一个捣蛋男孩怎么会用有限的文字把妈妈描绘的那么细腻感人……

     

    到了高中,他开始用新的方式表达对我们三口之家中唯一女士的关爱,送小礼物、骑自行车带我兜风、一起散步、一起买菜……每当我下班回家,只要他先到家,就开门,赶紧接下我身上背的、手里拎的东西……

     

    他是一个很会“算计”的男生,每月不多的零花前被他管理得很好。我来瑞士的时候,他用积攒下来的零花钱为我“换来”一个“安睡小天使”,别说,那“小天使”的模样还真是很像我!我带“她”来到了瑞士,现在她就在我的床头柜上。有她的陪伴,我的失眠毛病好了许多…….

     

    其实,最快乐的,还是我们三人一起外出,在他们两条大汉之间,“架着”我这个被他俩称作的“小矮人”……

     

    然而,我们三人到齐的时候并不多。每当我或先生离家多日,再见到儿子的时候,总是发现:他怎么又变了?

     

    儿子是在我们不在家的时候长大的...... 

    August 14

    The blue of Lausane before Rainstorm

     

    The Blue of Lausane Before Rainstorm

     

             Last week, after several days “high-speed running”, I went to Lausane where the Geneva lake flows through. Sitting on the lakeshore, I was attracted and intoxicated by that cobalt-scene! That is a cool but melancholy blue which only emergences at the moment before the rainstorm falls.
     
    August 12

    Bioed2008(Chinese Introduction). 2008生物教育国际会议将在法国勃艮第召开

    2008生物教育国际会议

    可持续发展,伦理与2020教育:

    生物学的挑战是什么

    国际生物科学协会教育委员会,联合国教科文组织,

    日内瓦大学科学认识论与教学实验室,

    CIMEOS研究室和科学文化使团勃艮第大学

    联合举办

    勃艮第:奥坦-欧塞尔-第戎(法国)

    2008 6 24日-28

     

     

         在过去的30年中,我们关于生物系统的知识已经得到了极大的增长,如分子学、有机体、人口、生态系统、地貌,以及整个生物圈。在此期间,生物学成为大多数社会问题——卫生/健康、环境、可持续发展——的主要参与因素,无论这些问题发生在家庭、在学校,还是在工作单位。今天,理解生物学概念、过程及方法的能力是任何一个参与为社会作贡献的人所必备的素养。然而,也是在这一时期,生物文盲的数量并没有减少,因此,“全民生物学”应当在学校、实验室、非政府组织、行政部门、社区、公司等地方得到阐述、完善与发展。

        尽管借助媒体与新的教育方法,人们可以更广泛地接触到生物学知识;尽管生物学在科学中心、博物馆都得到清晰的呈现,然而,研究者与公众之间的鸿沟仍在不断地扩大,学生表现出对生物学缺乏兴趣。与此同时,新的信息技术改变着我们与知识和实践之间的关系。

         因此,我们能否探索出生物教学的新视角?关键问题显然是不断变化的,研究单位,公司及社会整体将面对新的需求与挑战。在这样的情况下,生物学以及生物的教育、普及与传播的作用是什么?它们能为环境、健康/卫生,市民权力的问题,带来新的光芒吗?他们又如何为可持续发展作出贡献呢?

        从另一个角度讲,其他创新性生产部门(如集体或企业)的需求将作怎样的变化?什么样的知识将是重要的、可融合的,是学生应当学习的?以及为什么?什么问题是学生或公众将会提出的?他们与生物学有着怎样的关系?最好的教育方法和策略是什么?跨学科的方法如何?新的工具及教师、媒体、记者的新角色/作用,将以怎样的形式出现?学校、媒体和博物馆,以及其他社会团体,将如何增进生物学的觉知和文化?

        继巴黎(国家自然历史博物馆)2000BioEd与里约热内卢(奥斯瓦多克鲁兹基金会)2004BioEd之后,将在勃艮第举办的2008BioEd希望能解决上述问题。这一愿景的基础来自从教育到公民推广,从公司到大学,从非政府组织到集体等应用领域的创新及实证的或思辨的研究。

     

    会议宗旨

     

          2008生物教育会议旨在:

    l        探寻生物科学、环境、可持续发展与社会之间的联系;

    l        推动整合生物学、可持续发展、卫生/健康、人类幸福、伦理与市民权的生物素养与教育改革;

    l        提倡在世界范围内改进教育,以支持联合国可持续发展教育十年(20052015)项目。

     

    会议目标

     

         会议将:

    l        为可持续发展、伦理与市民权中的生物教育准备一份议程表;

    l        为在发达国家和发展中国家实施这一议程制定指导方针;

    l        联系整个教育界的科学与社会方面的领军人物,从正式教育(中间学校,中等学校,大学及研究生机构)到非正式教育,包括环境教育中的公共教育与培训,生物教育,农业教育,卫生/健康教育,以及工程技术教育;

    l        讨论在确定有关环境、可持续发展、卫生/健康与人类幸福的重要知识时面对的问题;

    l        讨论在探究应用新的教育技术与教学方法时,科学与价值观在教育中的作用问题;

    l        探讨并评估方法与主题的多样性,鼓励参与发现不同的主题与方法的共同基础;

    l        介绍如何发展面向可持续、伦理与市民权的生物素养。

    l        形成一份报告并借助硬拷贝与网络,通过简报及展示,广泛分发给国家及国际层面上的政策与决定制定者。

     

    参与人员与机构

        

        此次会议得到IUBS-CBE, 联合国教科文组织, UNEP,日内瓦大学科学认识论与教学实验室, SAPIENCE的赞助,邀请了科学家、教育家、哲学家及政要人员来解决会议的关键问题并形成本次会议的观点。

       

         会议将汇集约200300位科学家、生物教育者以及教师培训人员、政策制定者、商界人员与媒体专家,还有哲学家、神学家和伦理学家。来自世界各地的与会者将被邀请对他们的研究、实验以及实证与思辨的结论进行报告展示,并且对教育材料(海报、录像、展览、讲堂……)进行演示说明。

     

    会议由全会和平行分会构成,同时进行海报与教育材料展示会。讨论会与研讨会将围绕以下主题:

    l        生物教育,健康与人类幸福

    l        生物教育,环境与可持续发展

    l        生物教育,农业,营养与食品安全

    l        信息与交流技术当代中的生物教育

    l        生物教育,伦理与市民权

     

    组织委员会

     

              André GIORDAN      国际生物科学协会教育委员会主席

          Daniel RAICHVARG   2008生物教育会议组委会秘书长

          Talal YOUNÈS       国际生物科学协会常务主任

     

    科学委员会

    Atchia, Michael     IUBS-CBE前主席,毛里求斯

    Azzouna, Atf       突尼斯大学,突尼斯

    Babacar, Guèye     高等师范学院,达卡,塞内加尔

    Clément, Pierre      里昂大学,法国

    Giordan, André      IUBS-CBE 主席,日内瓦大学科学认识论与教学实验室,法国/瑞士

    Grynzspan, Danielle   奥斯瓦多克鲁兹基金会,里约热内卢,巴西

    Holtman, Lorna      西开普大学,贝尔维尔,南非

    Jungck, John R.     IUBS-CBE 副主席,IUBS生物与教育项目主席,美国

    Kalali, Faouzia       卡昂大学,摩洛哥

    Marquez Valderrama  国家大学,麦德林,哥伦比亚

    Mohr, Adriana       佛洛莉亚诺波里斯大学,巴西

    Pei, Xinning         华东师范大学,上海,中国

    Potyrała, Katarzyna   克拉科夫大学,波兰

    Raichvarg, Daniel     勃艮第大学,法国

    Samson, Ghislain     谢尔布鲁克大学,加拿大

    Teppa, Sonia        巴基西梅托大学,委内瑞拉

    Vohra, Faqir         IUBS CBE 秘书,马来西亚

    Younès, Talal        IUBS 常务主任,黎巴嫩/法国

     

    当地委员会

             Daniel Raichvarg     勃艮第大学 E-mail: daniel.raichvarg@u-bourgogne.fr

     

    详情请见:http://www.ldes.unige.ch/bioEd/bioEd2008.htm

     

     

    关于注册

           注册费用为240欧元 /  424前注册为200欧元  (含资料、茶歇、午餐以及626宴会)

    自行预定酒店   (各级酒店及生活费用目录:http://www.ldes.unige.ch/bioEd/sejour.htm

    其他信息与注册,请联系:Daniel.raichvarg@u-bourgogne.fr

     

    期待我们中国学者的参与! 如需帮助,敬请联系:

     

    中国华东师范大学课程与教学研究所,华东师范大学学习科学研究中心(目前在瑞士日内瓦大学LDES)

     

    裴新宁peixinning@hotmail.com